Regular health checkups and routine lab tests are vital in assessing these parameters and tracking the medications effectiveness over time
Compounded semaglutide is not an FDA-approved finished product, the agency does not review it for safety, effectiveness, or quality before marketing, and it is not a generic version of any approved brand
Subjects with complicated or severe diseases (e.g., stroke, diabetic complications, cardiac diseases, renal/hepatic disorders, psychiatric disorders, cancers) were excluded
[7] [8] Readers should check the current NICE Technology Appraisal for tirzepatide in weight management and the emc SmPC (medicines.org.uk) for the most up-to-date information on its licensed indications and eligibility criteria in the UK, as guidance may be updated